DUBLIN, Aug. 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018" report to their offering.
The global molecular biology enzymes market was valued at $2,847.63 million in 2013, and is expected to grow at a CAGR of 13.74% to reach $5,420.63 million in 2018. Molecular biology enzymes, kits, & reagents find applications in a large number of fields in life science research. They also find application in diagnostics and drug discovery research. These products are widely used for analysis of cell surface markers, which can act as diagnostics or therapeutic targets. PCR (polymerase chain reactions) is one of the most widely-used analytical and preparative techniques in molecular biology. It finds applications in large numbers of experimental procedures, like preparative PCR, RT-PCR, qPCR, and so on. As such, it is one of the largest application segments of the molecular biology enzymes market in 2013. PCR also finds applications in diagnostics, gene expression, and DNA fingerprinting.
This report provides a granular understanding of the molecular biology enzymes, kits & reagents market. This report segments the global molecular market on the basis of applications, end users, products and geographies. The application segments included in this report are cloning, epigenetics, PCR, restriction digestion, sequencing, and other applications. The end-user segments of this market are academic research institutes, hospitals and diagnostic centers, pharmaceutical and biotech companies, and other end users.
The product segments included in this report are enzymes, kits and reagents. The enzymes segment is divided into ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptase, and other enzymes. The ligases segment encompasses T4 DNA ligase, thermostable DNA ligase, and other ligases. The polymerase sub-segments are high-fidelity DNA polymerase, T4 DNA polymerase, Taq DNA polymerase, and other polymerases. The restriction endonucleases enzyme segments are sub-segmented into BamHI, EcoRI, PstI, and other restriction endonucleases. The kits and reagents segment is divided into cloning and mutagenesis, nucleic acid analysis, PCR, sequencing and other kits and reagents.
The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). Asia is divided into the regional segments of China, India, Japan, and Rest of Asia. The European geographic segment is divided into the regional segments of Germany, France, Italy, Spain, the U.K., and the Rest of Europe. The North American segment includes Canada, and the U.S. The RoW segment is further divided into Latin America, Middle East and Africa, and the Pacific countries. The report maps each application, end user and product segment in 19 geographic and regional segments.
The major players in the market include Affymetrix, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Enzymatics, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs, Inc. (U.S.), QIAGEN, N.V. (Netherlands), Roche, Ltd. (Switzerland), Sigma-Aldrich Co. LLC. (U.S), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (U.S.).
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Application
5 Global Molecular Biology Enzymes, Kits, & Reagents Market, By End User
6 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Product
7 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Geography
8 Competitive Landscape
9 Company Profiles
- Agilent Technologies
- New England Biolabs
- Sigma-Aldrich Co
- Takara Bio
- Thermo Fisher Scientific
For more information visit http://www.researchandmarkets.com/research/vlngb8/molecular_biology
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets